Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences
- At the beginning of this month, global healthcare firm Viatris Inc announced the completion of its Oyster Point Pharma and Famy Life Sciences acquisitions. The two companies will be combined, and their pipelines and infrastructure will be leveraged to support the new Viatris Eye Care Division. The transactions cost Viatris more than $700...
